Financial Information
Stock Information
Press Release

 

 

PRESS RELEASE

Subject : [AFP] S. Korea approves sales of new stem cell drug
Register : MEDIPOST
View/Date : Hit : 8541, Date : 2012/01/26 20:31

S. Korea approves sales of new stem cell drug


A South Korean researcher holds Cartistem, an allogeneic stem cell
drug developed by Seoul-based Medipost (AFP/Medipost)



SEOUL — South Korea's government drug agency cleared the way Thursday for commercial sales of what it called the world's first approved medicine using stem cells collected from other people.

Cartistem, developed by Seoul-based Medipost, will help regenerate knee cartilage using stem cells developed from newborns' umbilical cord blood, the Korea Food and Drug Administration said.

"Cartistem is... the world's first approved allogeneic (taken from different individuals of the same species) stem cell drug, that can offer new opportunity for treatment of patients with degenerative arthritis," the administration said in a statement.

Medipost said 27 billion won ($23.8 million) from private investors and government funds had been invested to develop Cartistem since 2001. The drug can be injected into a patient's knees via surgery.

Clinical trials have been under way in the United States since last year, the statement said.

Two of the world's top 10 drugmakers are in talks to seek a worldwide licence to make the drug, a Medipost spokesman told AFP, adding that final trials involving a large number of people would likely begin in the US in 2015.

 

All article: 86,  Current Page: 1/6
No. Subject Register Date View
86 [Press] MEDIPOST, lung disease stem cell treatment drug 'Pneumostem'.. MEDIPOST 2014/08/12 336
85 [Press] MEDIPOST, lung disease stem cell drug designated 'orphan dru.. MEDIPOST 2014/07/29 293
84 [Press] Hiddink, designated MEDIPOST Cord Blood Honorary Ambassador MEDIPOST 2014/07/23 306
83 [Press] MEDIPOST, Stem Cell Drug 'Cartistem' Treatment Japanese Pat.. MEDIPOST 2014/07/10 335
82 [Press] Medipost, US patent for 'CARTISTEM' raw material stem cell d.. MEDIPOST 2014/05/15 821
81 [Press] Medipost, successful administration of stem cell dementia tr.. MEDIPOST 2014/04/28 359
80 [Press] Medipost, Japan patent for dementia treatment technology usi.. MEDIPOST 2014/04/17 362
79 [Press] Medipost, stem cell treatment 'CARTISTEM' patient cutting th.. MEDIPOST 2014/03/27 398
78 [Press] Medipost, Stemcell cartilage differentiation technology Sing.. MEDIPOST 2014/03/18 360
77 [Press]Clinical thesis for lung treatment 'Pneumostem' published in.. MEDIPOST 2014/02/10 82
76 [Press] Football Manager Guus Hiddink, receives arthritis surgery wi.. MEDIPOST 2014/01/09 537
75 [Press] Medipost, designated 'Stem Cell Hair Growth Solution' resear.. MEDIPOST 2013/12/20 490
74 [Press] Medipost, signed license for 'Cartistem' in India MEDIPOST 2013/12/16 563
73 [Press] Medipost, strengthening marketing of 'Cartistem' by particip.. MEDIPOST 2013/12/09 406
72 [Press] Medipost Lung Treatment Medicine 'Pneumostem' designated Orp.. MEDIPOST 2013/12/05 462
1 2 3 4 5 6
       

21, Daewangpangyo-ro 644beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea

822-3465-6651

822-3465-6688